Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma

NCT06826118 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Follicular Lymphoma
Refractory Lymphoma

Interventions

DRUG: Axicabtagene Ciloleucel

Sponsor

The First Affiliated Hospital of Xiamen University